Dalsy ibuprofen oral suspension

Dalsy is a highly recognized ibuprofen-based medication specifically designed for pediatric use in Spain. It was originally developed and popularized by Laboratorios Abbott (Abbott Laboratories) in Spain, becoming a household name for treating fever and pain in children.

Over the years, the brand ownership transitioned through corporate mergers and acquisitions. It was part of the generic division that spun off into Mylan, which later merged with Upjohn (a division of Pfizer) to form Viatris. Currently, Viatris is the ultimate owner of the brand. Manufacturing for the Spanish market is predominantly handled in facilities located in Spain (such as the plant in Olot, Girona), though the parent company operates global supply chains. Dalsy remains a market leader in the Spanish pharmaceutical sector for children's anti-inflammatory medicine.